Clinical Trial Update: Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Immunoscore-based guidance for adjuvant chemotherapy in Stage III colon cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Johannes Laengle, MD, PhD | Conditions: Colon Cancer Stage III | Phase 3 | Status: WITHDRAWN